Kelly Lawrence W & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-32
| Closed | -$2K | – | 176 |
|
|
2022
Q2 | $2K | Buy |
+32
| New | +$2K | ﹤0.01% | 165 |
|
|
2019
Q1 | – | Sell |
-350
| Closed | -$18K | – | 129 |
|
|
2018
Q4 | $18K | Hold |
350
| – | – | ﹤0.01% | 118 |
|
|
2018
Q3 | $22K | Hold |
350
| – | – | ﹤0.01% | 122 |
|
|
2018
Q2 | $19K | Hold |
350
| – | – | ﹤0.01% | 124 |
|
|
2018
Q1 | $22K | Hold |
350
| – | – | ﹤0.01% | 125 |
|
|
2017
Q4 | $21K | Buy |
+350
| New | +$21K | ﹤0.01% | 138 |
|
|
2016
Q4 | – | Sell |
-199,315
| Closed | -$10.7M | – | 161 |
|
|
2016
Q3 | $10.7M | Buy |
199,315
+163,315
| +454% | +$8.81M | 2.3% | 19 |
|
|
2016
Q2 | $2.65M | Buy |
36,000
+32,000
| +800% | +$2.35M | 0.61% | 40 |
|
|
2016
Q1 | $256K | Hold |
4,000
| – | – | 0.06% | 80 |
|
|
2015
Q4 | $276K | Sell |
4,000
-600
| -13% | -$41.4K | 0.06% | 78 |
|
|
2015
Q3 | $273K | Sell |
4,600
-2,142
| -32% | -$127K | 0.06% | 78 |
|
|
2015
Q2 | $448K | Sell |
6,742
-25
| -0.4% | -$1.66K | 0.09% | 65 |
|
|
2015
Q1 | $437K | Sell |
6,767
-263
| -4% | -$17K | 0.09% | 61 |
|
|
2014
Q4 | $415K | Sell |
7,030
-175
| -2% | -$10.3K | 0.09% | 64 |
|
|
2014
Q3 | $369K | Hold |
7,205
| – | – | 0.08% | 65 |
|
|
2014
Q2 | $349K | Hold |
7,205
| – | – | 0.07% | 69 |
|
|
2014
Q1 | $374K | Sell |
7,205
-82
| -1% | -$4.26K | 0.09% | 65 |
|
|
2013
Q4 | $387K | Sell |
7,287
-1,000
| -12% | -$53.1K | 0.09% | 67 |
|
|
2013
Q3 | $383K | Sell |
8,287
-83
| -1% | -$3.84K | 0.09% | 64 |
|
|
2013
Q2 | $374K | Buy |
+8,370
| New | +$374K | 0.1% | 66 |
|